Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -303,261 | -247,249 | -68,075 | -29,509 | -89,084 |
| Depreciation Amortization | 2,705 | 2,191 | 1,508 | 691 | 2,002 |
| Accounts payable and accrued liabilities | 1,542 | -3,759 | -5,024 | -8,094 | 4,266 |
| Other Working Capital | 44,063 | 28,022 | 16,657 | -820 | 515 |
| Other Operating Activity | 150,988 | 148,472 | 14,973 | 12,709 | 8,190 |
| Operating Cash Flow | $-103,963 | $-72,323 | $-39,961 | $-25,023 | $-74,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -278 | -49 | -42 | -35 | -753 |
| Purchase Of Investment | -302,432 | -225,924 | -164,601 | -55,222 | -252,175 |
| Sale Of Investment | 278,580 | 188,662 | 119,527 | 57,861 | 122,640 |
| Other Investing Activity | -80,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-104,130 | $-37,311 | $-45,116 | $2,604 | $-130,288 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 278,246 | 278,252 | 278,238 | N/A | N/A |
| Common Stock Issued | 184,277 | 183,220 | 183,354 | 182,543 | 138,950 |
| Financing Cash Flow | $462,523 | $461,472 | $461,592 | $182,543 | $138,950 |
| Beginning Cash Position | 42,293 | 42,293 | 42,293 | 42,293 | 107,742 |
| End Cash Position | 296,723 | 394,131 | 418,808 | 202,417 | 42,293 |
| Net Cash Flow | $254,430 | $351,838 | $376,515 | $160,124 | $-65,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,963 | -72,323 | -39,961 | -25,023 | -74,111 |
| Capital Expenditure | -278 | -49 | -42 | -35 | -753 |
| Free Cash Flow | -104,241 | -72,372 | -40,003 | -25,058 | -74,864 |